According to a new study, testing how well high-density lipoprotein (HDL), or “good,” cholesterol reduces inflammation may help identify people who are more likely to develop cardiovascular disease associated with atherosclerosis. In the study, the anti-inflammatory capacity of good cholesterol was higher in people who did not experience cardiovascular events than in those who did.